MedTrace Logo

V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)

NCT00735839 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-12-21

Study results available
· View outcomes & findings →

Summary

This study is to evaluate the safety and immunogenicity of V710 in Japanese male subjects.

Conditions

  • Staphylococcal Infection

Interventions

BIOLOGICAL

V710

V710 vaccination (60 mcg, 0.5 ml) single injection on Day 1

BIOLOGICAL

Placebo

Saline placebo (0.5 ml) single injection on Day 1

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-06-30
Completion
2008-06-30

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00735839 on ClinicalTrials.gov